Literature DB >> 11503621

The FDA and The Lancet: an exchange.

A Walker.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11503621     DOI： 10.1016/S0140-6736(01)05564-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

Review 1.  Alosetron: a case study in regulatory capture, or a victory for patients' rights?

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2002-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.